Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

610 ARTÍCULOS , VIENDO DEL 481 AL 495

Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia

Goodall LS, Lennon MJ, Sachdev PS, Gorelick PB, Kovacic JC, Samaras K.

J Am Coll Cardiol. 2026 Jan 6;87(1):77-100. doi: 10.1016/j.jacc.2025.09.1502.

Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers

Sachdev PS, Bentvelzen AC, Gustafson D, Hansra GK, Hosoki S, Jiang J, Lennon MJ, Moro MA, Saks DG, Samaras K, Kovacic JC, Kalaria R.

J Am Coll Cardiol. 2026 Jan 6;87(1):52-76. doi: 10.1016/j.jacc.2025.11.008.

Mapping the neurovascular landscape in aging and dementia: cerebral small vessel disease markers in a multicenter Latin American cohort

Altschuler F, Castro-Laguardia AM, Canziani V, O'Byrne DF, Hazelton J, Migeot J, Maito M, García AM, Bruno MA, Magrath N, Slachevsky A, Behrens MI, Custodio N, Ávila-Funes JA, Matallana D, Aguillón D, Santamaria-García H, Resende E, Takada L, Brusco LI, Yokoyama JS, Miller B, Ibáñez A, Medel V, Campo CG.

Alzheimers Dement. 2026 May;22(5):e71468. doi: 10.1002/alz.71468.

Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease

Cetindag AC, Schipke CG, Esselmann H, Kruse N, Wiltfang J, Schneider A, Fliessbach K, Miklitz C, Maier F, Buerger K, Janowitz D, Ewers M, Stöcklein S, Perneczky R, Rauchmann BS, Kurz C, Teipel S, Kilimann I, Goerss D, Laske C, Sodenkamp S, Najafpour E, Wagner M, Roeske S, Frommann I, Stark M, Brosseron F, Ramirez A, Kleineidam L, Priller J, Spruth EJ, Gemenetzi M, Altenstein S, Düzel E, Glanz W, Incesoy EI, Butryn M, Bauer C, Jessen F, Peters O.

J Prev Alzheimers Dis. 2026 May;13(5):100544. doi: 10.1016/j.tjpad.2026.100544. Epub 2026 Mar 28.

What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Hazan J, Liu KY, Isaacs JD, Fox NC, Howard R.

Neurology. 2026 May 26;106(10):e214953. doi: 10.1212/WNL.0000000000214953. Epub 2026 May 4.

Redefining management of mild cognitive impairment and Alzheimer's disease through the shift from clinical to clinical-biological diagnosis: Insights from a single-center experience

Giuffrè GM, Battisti F, Tudor AM, Lenkowicz J, Avitabile A, Rosati AM, Martellacci N, Patarnello S, Torelli F, Cesario A, Marra C.

J Alzheimers Dis. 2026 Feb;109(4):1945-1954. doi: 10.1177/13872877251411461. Epub 2026 Jan 5.

Potential Neuroprotective Role of GLP-2 in Alzheimer's Disease: Clinical Observations, Mechanistic Insights, and Comparison with GLP-1

Czarnecki M, Baranowska-Bik A, Litwiniuk A, Kalisz M, Domańska A, Kurdyła A, Bik W.

Int J Mol Sci. 2026 Feb 6;27(3):1609. doi: 10.3390/ijms27031609.

The NIH toolbox emotion battery and cerebrospinal fluid biomarkers in Alzheimer's disease: findings from the multisite ARMADA study

Yu K, Gatchel JR, Ho EH, Hajjar I, Arnold SE, Marshall GA, Dodge HH.

J Gerontol B Psychol Sci Soc Sci. 2026 Jan 12;81(2):gbaf236. doi: 10.1093/geronb/gbaf236.

Multimodal biomarker AI techniques for early neurocognitive disorder diagnosis: A systematic review

Catino F, Castellana F, Zupo R, Giannoccaro V, Lampignano L, Petrosillo AM, Addabbo F, Sborgia G, Colacicco G, Santoro C, Boero G, Impedovo D, Zheng Y, Sardone R.

Artif Intell Med. 2026 Jul;177:103389. doi: 10.1016/j.artmed.2026.103389. Epub 2026 Mar 23.

Interactions Between Blood Nutritional Biomarkers and Apolipoprotein E ε4 in the Progression of Mild Cognitive Impairment in Alzheimer's Disease

Lawal R, Kumar S, Chigevenga R, Coe S.

Nutrients. 2026 Apr 16;18(8):1263. doi: 10.3390/nu18081263.

Sex differences in the relationship of biomarker change to memory decline in early Alzheimer's disease: an observational cohort study

Sundermann EE, Banks SJ, Bondi MW, Martinez MA, Biegon A, Rotblatt LJ, Hildebrandt T.

Biol Sex Differ. 2026 Jan 16;17(1):38. doi: 10.1186/s13293-025-00820-6.

The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review

Zecca V, Palombelli G, Vanacore N, Canese R.

J Magn Reson Imaging. 2026 Jun;63(6):1509-1545. doi: 10.1002/jmri.70296. Epub 2026 Mar 19.

Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population

Russell JK, Schlachetzki Z, Rafii MS.

Curr Opin Neurol. 2026 Apr 1;39(2):210-216. doi: 10.1097/WCO.0000000000001461. Epub 2026 Feb 18.

Synaptic biomarkers in Alzheimer's disease dementia and mild cognitive impairment: A systematic review and meta-analysis

Gaur A, Wong M, Chen JJ, Kang Y, Tahoulas D, Jeor K, Raguram KH, Gallagher D, Rapoport M, Herrmann N, Lanctôt KL.

Alzheimers Dement. 2026 May;22(5):e71501. doi: 10.1002/alz.71501.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias